{"product_id":"textbook-of-transplantation-and-mechanical-support-for-endstage-heart-and-lung-disease-2-volume-set-9781119633846","title":"Textbook of Transplantation and Mechanical","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eTextbook of Transplantation and Mechanical Support for End-Stage Heart and Lung Disease\u003c\/b\u003e \u003cp\u003e\u003cb\u003eComprehensive textbook covering all aspects of the care of patients with advanced heart or lung disease\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eTransplantation and Mechanical Support for End-Stage Heart and Lung Disease\u003c\/i\u003e is the most comprehensive and contemporary textbook available that addresses the medical and surgical treatment options for patients with end-stage heart and lung disease. All facets of these complex and resource-intensive therapies are covered by leading experts  including the basics of transplant immunology, databases, regulatory and ethical aspects of transplantation and conventional and new modalities of donor organ harvest.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eTransplantation and Mechanical Support for End-Stage Heart and Lung Disease\u003c\/i\u003e includes further information on topics such as:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eHistorical developments that facilitated heart and lung transplantation; engineering advances in continuous flow tech\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eSection IX The MCS Patient 785\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eStephan Schueler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Postoperative ICU Care for Mechanical Circulatory Support Patients 787\u003cbr\u003e\u003ci\u003eNicholas C. Cavarocchi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Post-ICU LVAD Course 797\u003cbr\u003e\u003ci\u003eMelissa Lyle and Divya Gupta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 The VAD Coordinator's Role: Education and Team Communication 805\u003cbr\u003e\u003ci\u003eHeidi Craddock and Christy Kay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 The LVAD Patient Bridging to Wellness: Psychological Assessment and Rehabilitation 812\u003cbr\u003e\u003ci\u003eMary Amanda Dew\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 LVAD Clinic: Outpatient Monitoring and Causes for Readmission 833\u003cbr\u003e\u003ci\u003eNancy K. Sweitzer and Sophia Airhart\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Hemodynamic Optimization of the LVAD Patient 849\u003cbr\u003e\u003ci\u003eNikhil Narang, Gabriel Sayer, and Nir Uriel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e62 Myocardial Recovery During LVAD Support 858\u003cbr\u003e\u003ci\u003eChristos P. Kyriakopoulos, Craig H. Selzman, and Stavros G. Drakos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection X MCS-Related Complications in the Chronic Patient 881\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJoseph G. Rogers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e63 Right Heart Failure: Risk Scores and Management 883\u003cbr\u003e\u003ci\u003eBrent C. Lampert and Jeffrey J. Teuteberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 LVAD-Associated Acquired von Willebrand Syndrome and Gastrointestinal Bleeding: Pathophysiology, Etiologies, and Management 898\u003cbr\u003e\u003ci\u003eSanjhai L. Ramdeen and Carlo R. Bartoli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 Mechanical Circulatory Support Infections 907\u003cbr\u003e\u003ci\u003eGerard Giblin, Ciara O’Connor, Emer Joyce, and Margaret M. Hannan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e66 Pump Thrombosis: Medical and Surgical Management 932\u003cbr\u003e\u003ci\u003eAndrew Xanthopoulos, Filippos Triposkiadis, and Randall C. Starling\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e67 Neurologic Complications: Pathophysiology, Incidence, Types, Prevention, and Management 945\u003cbr\u003e\u003ci\u003ePaolo C. Colombo, Chinwe Ibeh, Kara R. Melmed, and Joshua Willey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e68 Renal Dysfunction in MCS Patients: Perioperative and Long-Term Considerations 966\u003cbr\u003e\u003ci\u003eNatasha A. Vedage and Meredith A. Brisco-Bacik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e69 De Novo Aortic Insufficiency 977\u003cbr\u003e\u003ci\u003eJennifer Cowger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XI The LVAD Program and Future Directions 987\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDaniel J. Goldstein\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e70 Regulatory and Miscellaneous Aspects of an LVAD Program 989\u003cbr\u003e\u003ci\u003eChristina Cheyne, Igor Gosev, and Sunil Prasad\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e71 Current Limitations and Characteristics of Next-Generation Ventricular Assist Devices 996\u003cbr\u003e\u003ci\u003eYuji Kaku, Yoshifumi Naka, and Daniel Burkhoff\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e72 MCS and Novel Adjunctive Therapies: An Update 1011\u003cbr\u003e\u003ci\u003eDoris A. Taylor, Lourdes I. Chacon, Camila Hochman-Mendez, and Luiz C. Sampaio\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e73 Artificial Intelligence and Machine Learning in MCS 1021\u003cbr\u003e\u003ci\u003eManreet Kanwar, Marek J. Druzdzel, Faezeh Movahedi, and Jim Antaki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eLung Transplant\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XII The Pretransplant Phase: Recipient 1035\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMani A. Daneshmand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e74 Recipient Selection and the Lung Transplant Window for Adult and Pediatric Patients 1037\u003cbr\u003e\u003ci\u003eDavid C. Neujahr and William R. Hunt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e75 Advanced Lung Disease 1053\u003cbr\u003e\u003ci\u003eCynthia Jane Gries\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e76 The Acute Lung Failure Patient and Temporary Mechanical Support 1070\u003cbr\u003e\u003ci\u003ePurav Shah, Maria C. Creel, and Satish Chandrashekaran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e77 Preoperative Optimization for Lung Transplant 1081\u003cbr\u003e\u003ci\u003eAndrew M. Vekstein, John C. Haney, John M. Reynolds, and Jacob A.Klapper\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e78 Lung Transplant Waitlist Management 1089\u003cbr\u003e\u003ci\u003eJoshua B. Smith and Alice L. Gray\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XIII The Pretransplant Phase: Donor 1101\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eYaron D. Barac\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e79 Prioritization: Candidate Selection and Organ Allocation Systems 1103\u003cbr\u003e\u003ci\u003eAre Martin Holm andMatthew G. Hartwig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e80 Donor Lungs Evaluation 1110\u003cbr\u003e\u003ci\u003eLouis Stein, Alex Leung, Yaron D. Barac, Mani A. Daneshmand, and Yuri Pesachovitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e81 Lung Transplantation: Marginal Donors and Risk Assessment 1119\u003cbr\u003e\u003ci\u003eLaura L. Donahoe and Shaf Keshavjee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e82 Organ Procurement and Preservation 1132\u003cbr\u003e\u003ci\u003eReshma Biniwale and Abbas Ardehal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e83 Machines and Donation After Circulatory Death (DCD) in Lung Transplantation 1145\u003cbr\u003e\u003ci\u003eGabriel Loor and Pablo Sanchez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XIV The Transplant Phase 1163\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMani A. Daneshmand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e84 Components of the Lung Transplant Team 1165\u003cbr\u003e\u003ci\u003eKeshava Rajagopal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e85 Anesthesia and Hemodynamic Management for Lung Transplantation 1167\u003cbr\u003e\u003ci\u003eAngela Pollak, Charles Overbeek, and Brandi Bottiger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e86 Techniques in Lung Transplantation 1183\u003cbr\u003e\u003ci\u003eMaziar Khorsandi, Jeffrey Keenan, and Matthew Hartwig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e87 Technical Considerations in the Complex Recipient 1193\u003cbr\u003e\u003ci\u003eJamil F. Borgi and Stephen J. Forest\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e88 Taking the First Breath: ICU Care of the Lung Transplant Patient 1204\u003cbr\u003e\u003ci\u003eDaniel Herr and Patrick Odonkor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XV The Post-Transplant Phase 1215\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eYaron D. Barac\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e89 Post-Transplant Phase: Issues in the Early Postoperative Period 1217\u003cbr\u003e\u003ci\u003eJohn Mackintosh and Peter Hopkins\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e90 Post-Transplant Phase: From ICU Discharge to Hospital Discharge 1240\u003cbr\u003e\u003ci\u003eOsnat Shtraichman and Mordechai R. Kramer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e91 Lung Transplant Rejection 1268\u003cbr\u003e\u003ci\u003eCaroline Patterson and Martin Goddard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e92 Transplant Infectious Diseases 1288\u003cbr\u003e\u003ci\u003eGrace Chan, Breda Lynch, Michelle Murray, and Margaret M. Hannan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e93 Post-Transplant Complications 1317\u003cbr\u003e\u003ci\u003eJagan Murugachandran, Debra Thomas, and Jasvir Parmar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e94 Post-Transplant Other Adverse Events 1333\u003cbr\u003e\u003ci\u003eAndres Pelaez and Karoun H. Bagamian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e95 Survival and Quality of Life Post Lung Transplantation 1345\u003cbr\u003e\u003ci\u003eAttawar Sandeep, Vijil Rahulan, and Unmil Shah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XVI Thoracic Transplant in a Long-Term Perspective 1359\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMani A. Daneshmand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e96 The Future of Heart and Lung Transplantation 1361\u003cbr\u003e\u003ci\u003eJane M.O., David C. Becerra, and Joren C. Madsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e97 Heart and Lung Xenotransplantation 1389\u003cbr\u003e\u003ci\u003eJane O., Cynthia L. Miller, and Joren C. Madsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 1404\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407104975191,"sku":"9781119633846","price":270.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119633846.jpg?v=1730498193","url":"https:\/\/bookcurl.com\/products\/textbook-of-transplantation-and-mechanical-support-for-endstage-heart-and-lung-disease-2-volume-set-9781119633846","provider":"Book Curl","version":"1.0","type":"link"}